These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3903566)

  • 21. Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement.
    Rudling MJ; Angelin B; Peterson CO; Collins VP
    Cancer Res; 1990 Feb; 50(3):483-7. PubMed ID: 2297691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.
    Mistry P; Miller NE; Laker M; Hazzard WR; Lewis B
    J Clin Invest; 1981 Feb; 67(2):493-502. PubMed ID: 6257763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Catabolism of low-density lipoproteins via receptors and its regulation].
    Mazière JC; Mazière C; Gardette J; Polonovski J
    Ann Biol Clin (Paris); 1986; 44(5):545-50. PubMed ID: 3544977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-density lipoprotein receptor deficiency resulting in familial hypercholesterolaemia in a black man. A follow-up study.
    Coetzee GA; van Wingerden JJ; van der Westhuyzen DR
    S Afr Med J; 1985 Feb; 67(7):259-61. PubMed ID: 3983774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by low density lipoprotein in human lymphocytes.
    Krone W; Betteridge DJ; Galton DJ
    Eur J Clin Invest; 1979 Oct; 9(5):405-10. PubMed ID: 230062
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages.
    Angelin B
    Biochem J; 1988 Oct; 255(2):529-34. PubMed ID: 3202831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The LDL receptor.
    Goldstein JL; Brown MS
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):431-8. PubMed ID: 19299327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase expression by Zingiber officinale in the liver of high-fat diet-fed rats.
    Nammi S; Kim MS; Gavande NS; Li GQ; Roufogalis BD
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):389-95. PubMed ID: 20002065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [he Nobel Prize for Medicine 1985: studies by M.S. Brown and J.L. Goldstein on (the lack of) control of cholesterol metabolism].
    Hülsmann WC
    Ned Tijdschr Geneeskd; 1986 Feb; 130(5):195-7. PubMed ID: 3513032
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipoprotein metabolism in familial hypercholesterolemia.
    Shepherd J; Packard CJ
    Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regulation of hepatocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase in primary cell cultures through low density lipoproteins].
    Gaertner U
    Z Gastroenterol; 1978 Apr; 16(4):251-6. PubMed ID: 207027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic effects of portacaval shunt surgery and liver transplantation in familial hypercholesterolemia.
    Bilheimer DW
    Beitr Infusionsther; 1988; 23():61-73. PubMed ID: 2484783
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
    Bilheimer DW; East C; Grundy SM; Nora JJ
    Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normalization of low-density lipoprotein receptor expression in receptor defective homozygous familial hypercholesterolemia by inhibition of PCSK9 with alirocumab.
    Lambert G; Chatelais M; Petrides F; Passard M; Thedrez A; Rye KA; Schwahn U; Gusarova V; Blom DJ; Sasiela W; Marais AD
    J Am Coll Cardiol; 2014 Dec; 64(21):2299-300. PubMed ID: 25456764
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluorescent low density lipoprotein for observation of dynamics of individual receptor complexes on cultured human fibroblasts.
    Barak LS; Webb WW
    J Cell Biol; 1981 Sep; 90(3):595-604. PubMed ID: 6270157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease.
    Williams JC; Weinstein DB; Miller AL; Steinberg D
    Biochem J; 1982 Jan; 202(1):183-90. PubMed ID: 7082306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolite regulation of cholesterol synthesis.
    Javitt NB
    Hosp Pract (Off Ed); 1985 Oct; 20(10):109-12, 116-7, 120-1. PubMed ID: 3930530
    [No Abstract]   [Full Text] [Related]  

  • 39. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary hypercholesterolemia].
    Kajinami K; Mabuchi H
    Nihon Rinsho; 1990 Nov; 48(11):2532-9. PubMed ID: 2270017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.